Acceleron In Advanced $11B Buyout Talks: Bloomberg
Frothy rumors about possible M&A discussions at Acceleron Pharma Inc (NASDAQ:XLRN) were capped with a Bloomberg report asserting that the Company is…
7 Members Of Congress Failed To Disclose Stock Transactions: Who Was Named, And What’s Next?
The call for members of Congress to be banned from buying and selling stocks continues to heat up with a new report that seven members of the House of Representatives failed to disclose their stock trades.
Gilead’s Remdesivir Cuts Risk of Hospitalization In High-Risk COVID-19 Patients
Gilead Sciences Inc (NASDAQ:GILD) announced positive results from a Phase 3 trial of Veklury (remdesivir) non-hospitalized COVID-19 patients at high risk…
EXCLUSIVE: NanoViricides’ Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile
NanoViricides Inc (NYSE: NNVC) has reported significant advantages gained by remdesivir encapsulation within its lead COVID-19 candidate, thus showing a potential pan-coronavirus cure.
Gilead To Present Latest Antiviral Research Data Addressing Urgent Global Needs In Infectious Disease At IDWeek 2021
Gilead Sciences, Inc. (NASDAQ:GILD) today announced the upcoming presentation of new data from the company’s virology research and development programs at the virtual IDWeek 2021 conference, taking place September
Barron’s Latest Picks And Pans: Apple, Bitcoin, a Goldman Sachs ETF, Nike And More
This weekend's Barron's cover story examines the threats and opportunities as currencies go digital.
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera’s COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 16)
Gilead Churns Out Additional Trodelvy Data
Gilead Sciences Inc (NASDAQ:GILD) announced new data from the Phase 3 ASCENT study of Trodelvy (sacituzumab govitecan-hziy) in relapsed or refractory…